ZA201300050B - Use of bacterial beta-lactamase for in vitro diagnostics and in vivo imaging,diagnostics and therapeutics - Google Patents

Use of bacterial beta-lactamase for in vitro diagnostics and in vivo imaging,diagnostics and therapeutics

Info

Publication number
ZA201300050B
ZA201300050B ZA2013/00050A ZA201300050A ZA201300050B ZA 201300050 B ZA201300050 B ZA 201300050B ZA 2013/00050 A ZA2013/00050 A ZA 2013/00050A ZA 201300050 A ZA201300050 A ZA 201300050A ZA 201300050 B ZA201300050 B ZA 201300050B
Authority
ZA
South Africa
Prior art keywords
diagnostics
lactamase
therapeutics
vivo imaging
bacterial beta
Prior art date
Application number
ZA2013/00050A
Other languages
English (en)
Inventor
Jeffrey D Cirillo
James C Sachettini
Jianghong Rao
Hexin Xie
Original Assignee
Texas A & M Univ Sys
Univ Leland Stanford Junior
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Texas A & M Univ Sys, Univ Leland Stanford Junior filed Critical Texas A & M Univ Sys
Publication of ZA201300050B publication Critical patent/ZA201300050B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0028—Oxazine dyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0032—Methine dyes, e.g. cyanine dyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0041—Xanthene dyes, used in vivo, e.g. administered to a mice, e.g. rhodamines, rose Bengal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0052—Small organic molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/978—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • G01N2333/986—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in cyclic amides (3.5.2), e.g. beta-lactamase (penicillinase, 3.5.2.6), creatinine amidohydrolase (creatininase, EC 3.5.2.10), N-methylhydantoinase (3.5.2.6)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
ZA2013/00050A 2010-06-04 2013-01-03 Use of bacterial beta-lactamase for in vitro diagnostics and in vivo imaging,diagnostics and therapeutics ZA201300050B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12/802,340 US20110020240A1 (en) 2008-08-06 2010-06-04 Use of bacterial beta-lactamase for in vitro diagnostics and in vivo imaging, diagnostics and therapeutics
PCT/US2011/001018 WO2011152883A2 (en) 2010-06-04 2011-06-03 Use of bacterial beta-lactamase for in vitro diagnostics and in vivo imaging, diagnostics and therapeutics

Publications (1)

Publication Number Publication Date
ZA201300050B true ZA201300050B (en) 2013-09-25

Family

ID=45067221

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2013/00050A ZA201300050B (en) 2010-06-04 2013-01-03 Use of bacterial beta-lactamase for in vitro diagnostics and in vivo imaging,diagnostics and therapeutics

Country Status (10)

Country Link
US (1) US20110020240A1 (enExample)
EP (1) EP2585611A4 (enExample)
JP (1) JP2013528386A (enExample)
KR (1) KR20130132722A (enExample)
CN (1) CN103038359A (enExample)
AU (1) AU2011262374A1 (enExample)
CA (1) CA2801299A1 (enExample)
RU (1) RU2012157279A (enExample)
WO (1) WO2011152883A2 (enExample)
ZA (1) ZA201300050B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050227309A1 (en) * 2004-01-21 2005-10-13 Corry Schuyler B Optically-detectable enzyme substrates and their method of use
EP2823050B1 (en) * 2012-03-08 2017-03-01 Julius-Maximilians-Universität Würzburg Diagnostic chewing gum for pathogens
CN102633742A (zh) * 2012-03-22 2012-08-15 盛世泰科生物医药技术(苏州)有限公司 一种2-(6-羟基苯并[d]噻唑-2-基)噻唑-4-羧酸钠的合成方法
CN103360385A (zh) * 2012-04-06 2013-10-23 上海交通大学医学院附属第三人民医院 一种治疗mrsa感染的化合物和药物
US9677112B2 (en) * 2012-05-15 2017-06-13 The Texas A&M University System β-lactamase substrates and methods of their use for the diagnosis of tuberculosis
US11268958B2 (en) 2012-09-14 2022-03-08 The Johns Hopkins University Bacteria-specific labeled substrtates as imaging biomarkers to diagnose, locate, and monitor infections
CN104714006B (zh) * 2015-02-04 2017-10-20 国家纳米科学中心 一种检测奶制品中β‑内酰胺酶的方法
CN104697970A (zh) * 2015-03-17 2015-06-10 华中科技大学同济医学院附属协和医院 一种三维重建观察细胞在载体内增殖分布的方法
CN107703130A (zh) * 2017-09-19 2018-02-16 淮海工学院 适用于检测牛奶中残留的β‑内酰胺酶的色差检测方法
CN110551497B (zh) * 2019-09-15 2022-06-10 四川农业大学 一种分子印迹量子点磷光探针的制备方法及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5407957A (en) * 1990-02-13 1995-04-18 Martek Corporation Production of docosahexaenoic acid by dinoflagellates
US5338843A (en) * 1992-01-30 1994-08-16 Becton, Dickinson And Company Fluorogenic and chromogenic β-lactamase substrates
US7427680B2 (en) * 2001-01-12 2008-09-23 The Regents Of The University Of California Fluorogenic substrates for BETA-lactamase gene expression
US6166231A (en) * 1998-12-15 2000-12-26 Martek Biosciences Corporation Two phase extraction of oil from biomass
SE0302840D0 (sv) * 2003-10-29 2003-10-29 Affibody Ab Detection method
US20070048848A1 (en) * 2005-08-25 2007-03-01 Sunsource Industries Method, apparatus and system for biodiesel production from algae
BRPI0917478A8 (pt) * 2008-08-06 2017-05-23 Univ Leland Stanford Junior uso de beta-lactamase bacteriana para diagnóstico in vitroe geração de imagem, diagnóstico e terapêutica in vivo

Also Published As

Publication number Publication date
WO2011152883A3 (en) 2012-03-29
CA2801299A1 (en) 2011-12-08
AU2011262374A1 (en) 2013-01-24
EP2585611A2 (en) 2013-05-01
KR20130132722A (ko) 2013-12-05
WO2011152883A2 (en) 2011-12-08
EP2585611A4 (en) 2013-12-04
RU2012157279A (ru) 2014-07-20
JP2013528386A (ja) 2013-07-11
CN103038359A (zh) 2013-04-10
US20110020240A1 (en) 2011-01-27

Similar Documents

Publication Publication Date Title
IL234782A0 (en) Use of bacterial beta-lactamase for in vitro diagnostics and in vitro imaging and diagnostics
ZA201300050B (en) Use of bacterial beta-lactamase for in vitro diagnostics and in vivo imaging,diagnostics and therapeutics
EP2575602A4 (en) MEDICAL IMAGING SYSTEM AND ASSOCIATED METHODS
EP2563225A4 (en) PHOTOACUSTIC CONVERTER AND IMAGING SYSTEM
EP2384143B8 (en) Mobile medical imaging system and methods
PT2534136T (pt) Métodos para sintetizar agentes de imagiologia, e seus intermediários
EP2539005A4 (en) ORAL PIECE AND METHODS OF USING THE SAME
ZA201208453B (en) Microbial process and composition for agricultural use
ZA201300612B (en) Novel bacteria and methods of use thereof
EP2413794A4 (en) Support component for use in imaging by magnetic resonance and x-ray
GB201013436D0 (en) Electrochemical measurements and functional imaging
ZA201205377B (en) Cancer diagnosis and imaging
IL222514A0 (en) Immuno-pet imaging of antibodies and immunoconjugates and uses therefor
EP2641525A4 (en) In vivo examination apparatus and capsule endoscope
IL226289A0 (en) Derivatives of one–@–benzothiazin–@@@–h4–yl–1–piperazin–2 and their use in the treatment of mammalian infections
IL217748A0 (en) Methods and compositions for diagnostics use in cancer patients
IL221730A0 (en) Derivatives of aminoindanes, their preparation and their application in therapeutics
GB201016038D0 (en) In vivo imaging method
GB2486967B (en) Soft field tomography system and method
IL199618A0 (en) Novel antibodies and their use in diagnostic methods
PL2531039T3 (pl) Zastosowanie sialidazy w technologii mleczarskiej
GB0917612D0 (en) In vivo imaging agents
GB201012209D0 (en) In vivo imaging agent
PL2453217T3 (pl) Bezspoinowy korpus wagi oraz metoda jego produkcji
WO2012040108A3 (en) Multivalent fluorescent probes